TCL Archive Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program. May 21, 2004
TCL Archive Cooperative Group Reorganization To Be Offered By DeVita At Clinical Trials Review Next March October 20, 1978
TCL Archive Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years May 9, 2014
